OEM Supply 99% Purity API Raw Powder Baricitinib Phosphate Salt with Premium Quality CAS 1187595-84-1
Min.Order / FOB Price:Get Latest Price
| 10 Gram |
Negotiable |
- Min.Order :10 Gram
- Purity: 99%min
- Payment Terms : T/T,
Keywords
99% Baricitinib phosphate salt API Baricitinib phosphate salt Powder Raw Powder Baricitinib phosphate salt
Quick Details
- Appearance:White Crystalline Powder
- Application:Pharmaceutical Raw Material
- PackAge:100g/ bag, 2 kg/ bag, 25kg/ carton or as required
- ProductionCapacity:1000|Metric Ton|Month
- Storage:Dry and Cool Place
- Transportation:By DHL, TNT, FedEx, HKEMS, UPS, Etc
Superiority:
Advantages:
Hubei XinRunde Chemical Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high quality products at competitive price in quick delivery with 100% custom pass guaranteed. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay and many other countries.
1. Quality.Every batch of steroid powders have tobetested by our QC(quality control) before they are allowed to sell.
2. Delivery We have stock, so we can delivery quickly at the very day when receive the payment. Within 24 hours after receiving the payment Lead time 4 or 7 days.
3. Discreet package Safelyand Professionally Disguised Package Guaranteed. For your safety and to insure delivery all products will be packed in a discreet way to prevent any suspicions, no steroids related name will appear on the parcels. high successful delivery rate.
4. Warm after-sale service Any of your question would be solved for the first as soon as possible.
Details:
Product name: Baricitinib phosphate salt;
CAS: 1187595-84-1
MF: C16H20N7O6PS
MW: 469.412061
Application: Baricitinib phosphate (LY3009104 phosphate; INCB028050 phosphate) is a selective orally bioavailable JAK1/JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, respectively. Baricitinib phosphate (INCB028050 phosphate) treatment, compares with the vehicle, inhibits the increase in hind paw volumes during the 2 wk of treatment by 50% at a dose of 1 mg/kg and >95% at doses of 3 or 10 mg/kg. Because baseline paw volume measurements are taken on treatment day 0-in animals with significant signs of disease-it is possible to have >100% inhibition in animals showing marked improvement in the swelling. Baricitinib (0.7 mg/day) treated mice exhibits substantially reduced inflammation as assessed by H&E staining, reduced CD8 infiltration, and reduced MHC class I and class II expression when compared with vehicle-control treated mice. CD8+NKG2D+ cells, critical effectors of disease in murine and human alopecia areata (AA), are greatly diminished in Baricitinib treated mice compared with vehicle control-treated mice.
You Might Also Like
-
98%min Nicotinamide Riboside Chloride CAS 23111-00-4
CAS NO:23111-00-4
-
Pharmaceutical Grade CAS 58-85-5 D-Biotin / Vitamin H/Biotin with GMP Standard for Vasodilator
CAS NO:58-85-5
-
Raw Steroid Powder 99%min Melatonine Manufacturer 73-31-4 For Well Sleep And Whitening
CAS NO:73-31-4
-
Weight Loss Powder Orlistat 96829-58-2 Treating Obesity Slimming
CAS NO:96829-58-2
-
17β-estradiol Pharmaceutical Intermediate Estradiol Estrogen Steroids CAS 50-28-2
CAS NO:50-28-2
-
Man Enhancement Steroids Tadalafil with Safetest Delivery (CAS 171596-29-5)
CAS NO:171596-29-5
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View